Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

FRA:AMC - Deutsche Boerse Ag - US0126531013 - Common Stock - Currency: EUR

79.59  +0.17 (+0.21%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMC. AMC was compared to 60 industry peers in the Chemicals industry. Both the profitability and financial health of AMC have multiple concerns. AMC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AMC had positive earnings in the past year.
In the past year AMC had a positive cash flow from operations.
Each year in the past 5 years AMC has been profitable.
In the past 5 years AMC always reported a positive cash flow from operatings.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

1.2 Ratios

The Return On Assets of AMC (-11.27%) is worse than 82.46% of its industry peers.
With a Return On Equity value of -19.21%, AMC is not doing good in the industry: 77.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.27%
ROE -19.21%
ROIC N/A
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

AMC's Profit Margin has declined in the last couple of years.
AMC's Operating Margin has declined in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for AMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMC has been increased compared to 1 year ago.
AMC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMC has a worse debt to assets ratio.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

AMC has an Altman-Z score of 1.56. This is a bad value and indicates that AMC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMC (1.56) is worse than 64.91% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that AMC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, AMC is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACCN/A
WACC8.1%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 2.44. This indicates that AMC is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.44, AMC is doing good in the industry, outperforming 71.93% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that AMC should not have too much problems paying its short term obligations.
The Quick ratio of AMC (1.58) is better than 75.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.58
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

4

3. Growth

3.1 Past

AMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.93%.
The Earnings Per Share has been growing by 32.24% on average over the past years. This is a very strong growth
AMC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.20%.
AMC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.30% yearly.
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%

3.2 Future

AMC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.38% yearly.
Based on estimates for the next years, AMC will show a small growth in Revenue. The Revenue will grow by 2.39% on average per year.
EPS Next Y-108.56%
EPS Next 2Y-85.82%
EPS Next 3Y-43.54%
EPS Next 5Y-2.38%
Revenue Next Year-41.6%
Revenue Next 2Y-23.95%
Revenue Next 3Y-11.92%
Revenue Next 5Y2.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 137.22, the valuation of AMC can be described as expensive.
AMC's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.47, AMC is valued quite expensively.
A Price/Forward Earnings ratio of 183.93 indicates a quite expensive valuation of AMC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMC indicates a slightly more expensive valuation: AMC is more expensive than 66.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, AMC is valued quite expensively.
Industry RankSector Rank
PE 137.22
Fwd PE 183.93
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as AMC's earnings are expected to decrease with -43.54% in the coming years.
PEG (NY)N/A
PEG (5Y)4.26
EPS Next 2Y-85.82%
EPS Next 3Y-43.54%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.89%, AMC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.94, AMC has a dividend in line with its industry peers.
AMC's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.89%

5.2 History

The dividend of AMC has a limited annual growth rate of 3.69%.
Dividend Growth(5Y)3.69%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-13.67%
EPS Next 2Y-85.82%
EPS Next 3Y-43.54%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

More info and screens

ALBEMARLE CORP

FRA:AMC (2/4/2025, 7:00:00 PM)

79.59

+0.17 (+0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-12 2025-02-12/amc
Inst Owners95.31%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap9.36B
Analysts69.03
Price Target106.31 (33.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.89%
Yearly Dividend1.6
Dividend Growth(5Y)3.69%
DP-13.67%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-249.28%
Max EPS beat(2)-90.28%
EPS beat(4)1
Avg EPS beat(4)-65.31%
Min EPS beat(4)-249.28%
Max EPS beat(4)81.63%
EPS beat(8)4
Avg EPS beat(8)-22.65%
EPS beat(12)8
Avg EPS beat(12)-10.42%
EPS beat(16)12
Avg EPS beat(16)-2.63%
Revenue beat(2)1
Avg Revenue beat(2)1.81%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)5.88%
Revenue beat(4)3
Avg Revenue beat(4)3.35%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)6.99%
Revenue beat(8)3
Avg Revenue beat(8)-0.88%
Revenue beat(12)4
Avg Revenue beat(12)-0.81%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)-4.82%
PT rev (3m)2.76%
EPS NQ rev (1m)-9.77%
EPS NQ rev (3m)-172.21%
EPS NY rev (1m)-3.26%
EPS NY rev (3m)-840.28%
Revenue NQ rev (1m)-1.68%
Revenue NQ rev (3m)-22.01%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 137.22
Fwd PE 183.93
P/S 1.49
P/FCF N/A
P/OCF 16.03
P/B 0.94
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)0.58
EY0.73%
EPS(NY)0.43
Fwd EY0.54%
FCF(TTM)-11.61
FCFYN/A
OCF(TTM)4.97
OCFY6.24%
SpS53.52
BVpS84.3
TBVpS68.79
PEG (NY)N/A
PEG (5Y)4.26
Profitability
Industry RankSector Rank
ROA -11.27%
ROE -19.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.57%
ROCE(5y)8.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 353.56%
Cap/Sales 30.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.58
Altman-Z 1.56
F-Score3
WACC8.1%
ROIC/WACCN/A
Cap/Depr(3y)431.6%
Cap/Depr(5y)412.07%
Cap/Sales(3y)22.75%
Cap/Sales(5y)23.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
EPS Next Y-108.56%
EPS Next 2Y-85.82%
EPS Next 3Y-43.54%
EPS Next 5Y-2.38%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%
Revenue Next Year-41.6%
Revenue Next 2Y-23.95%
Revenue Next 3Y-11.92%
Revenue Next 5Y2.39%
EBIT growth 1Y-165.41%
EBIT growth 3Y-5.49%
EBIT growth 5Y-9.1%
EBIT Next Year-47.73%
EBIT Next 3Y-4.36%
EBIT Next 5Y16.12%
FCF growth 1Y-358.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.46%
OCF growth 3Y18.38%
OCF growth 5Y19.4%